S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

JANX Janux Therapeutics Inc

29.25

0.00 (0.00%)

Pre Market

Last Updated: 20:02:59

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Janux Therapeutics (NASDAQ:JANX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Janux Therapeutics Charts.

Janux Therapeutics (NASDAQ:JANX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Janux Therapeutics Charts.

Janux Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 March 2025 (6 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 4 March 2025 (1 week ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 28 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 28 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 28 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Friday 28 February 2025 (2 weeks ago) • Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer
Saturday 25 January 2025 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 9 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 8 January 2025 (2 months ago) • Edgar (US Regulatory)

More Janux Therapeutics Inc News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions